Gasalia Tablet
FDA Label NDC 0220-9134

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Laboratoires Boiron for the product Gasalia (NDC 0220-9134). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, otc - stop use, otc - when using, otc - keep out of reach of children, description, other, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Stop Use

Stop use and ask a doctor if symptoms persist continuously for more than 7 days or worsen.

Otc - When Using

If pregnant or breast-feeding, ask a health professional before use.

Inactive Ingredient

Croscarmellose sodium, lactose, magnesium stearate.

Warnings


* Please review the disclaimer below.